Package 73190-003-60

{"route": ["ORAL"], "spl_id": "40bb1993-bba7-16ed-e063-6294a90a3870", "openfda": {"nui": ["N0000182142", "N0000008832", "N0000182143", "N0000182141", "N0000185503"], "upc": ["0373190003602"], "unii": ["GLH0314RVC"], "rxcui": ["1666332"], "spl_set_id": ["40bb0fb0-2275-4df7-e063-6394a90ade2e"], "pharm_class_pe": ["Decreased Platelet Aggregation [PE]"], "pharm_class_epc": ["P2Y12 Platelet Inhibitor [EPC]"], "pharm_class_moa": ["P2Y12 Receptor Antagonists [MoA]", "Cytochrome P450 3A4 Inhibitors [MoA]", "P-Glycoprotein Inhibitors [MoA]"], "manufacturer_name": ["AvKARE"], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "60 TABLET in 1 BOTTLE (73190-003-60)", "package_ndc": "73190-003-60", "marketing_start_date": "20251009"}], "brand_name": "TICAGRELOR", "product_id": "73190-003_40bb1993-bba7-16ed-e063-6294a90a3870", "dosage_form": "TABLET", "pharm_class": ["Cytochrome P450 3A4 Inhibitors [MoA]", "Decreased Platelet Aggregation [PE]", "P-Glycoprotein Inhibitors [MoA]", "P2Y12 Platelet Inhibitor [EPC]", "P2Y12 Receptor Antagonists [MoA]"], "product_ndc": "73190-003", "generic_name": "TICAGRELOR", "labeler_name": "AvKARE", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "TICAGRELOR", "active_ingredients": [{"name": "TICAGRELOR", "strength": "60 mg/1"}], "application_number": "ANDA208596", "marketing_category": "ANDA", "marketing_start_date": "20251009", "listing_expiration_date": "20261231"}